Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.

Abstract

PURPOSE We performed a case-control genome-wide association study (GWAS) to identify single nucleotide polymorphisms (SNPs) associated with musculoskeletal adverse events (MS-AEs) in women treated with aromatase inhibitors (AIs) for early breast cancer. PATIENTS AND METHODS A nested case-control design was used to select patients enrolled onto the MA.27 phase III trial comparing anastrozole with exemestane. Cases were matched to two controls and were defined as patients with grade 3 or 4 MS-AEs (according to the National Cancer Institute's Common Terminology Criteria for Adverse Events v3.0) or those who discontinued treatment for any grade of MS-AE within the first 2 years. Genotyping was performed with the Illumina Human610-Quad BeadChip. RESULTS The GWAS included 293 cases and 585 controls. A total of 551,358 SNPs were analyzed, followed by imputation and fine mapping of a region of interest on chromosome 14. Four SNPs on chromosome 14 had the lowest P values (2.23E-06 to 6.67E-07). T-cell leukemia 1A (TCL1A) was the gene closest (926-7000 bp) to the four SNPs. Functional genomic studies revealed that one of these SNPs (rs11849538) created an estrogen response element and that TCL1A expression was estrogen dependent, was associated with the variant SNP genotypes in estradiol-treated lymphoblastoid cells transfected with estrogen receptor alpha and was directly related to interleukin 17 receptor A (IL17RA) expression. CONCLUSION This GWAS identified SNPs associated with MS-AEs in women treated with AIs and with a gene (TCL1A) which, in turn, was related to a cytokine (IL17). These findings provide a focus for further research to identify patients at risk for MS-AEs and to explore the mechanisms for these adverse events.

DOI: 10.1200/JCO.2010.28.5064
01002003002008200920102011201220132014201520162017
Citations per Year

897 Citations

Semantic Scholar estimates that this publication has 897 citations based on the available data.

See our FAQ for additional information.

Cite this paper

@article{Ingle2010GenomewideAA, title={Genome-wide associations and functional genomic studies of musculoskeletal adverse events in women receiving aromatase inhibitors.}, author={James N. Ingle and Daniel J. Schaid and Paul E Goss and Mohan Liu and Taisei Mushiroda and J. W. Chapman and Michiaki Kubo and Gregory D. Jenkins and Anthony J. Batzler and Lois E. Shepherd and Joseph L. Pater and Liewei Wang and Matthew J. Ellis and Vered Stearns and Daniel C. Rohrer and Matthew P. Goetz and Kathleen I. Pritchard and David A. Flockhart and Yusuke Nakamura and Richard M. Weinshilboum}, journal={Journal of clinical oncology : official journal of the American Society of Clinical Oncology}, year={2010}, volume={28 31}, pages={4674-82} }